Literature DB >> 7499402

Effect of ionizing radiation on AP-1 binding activity and basic fibroblast growth factor gene expression in drug-sensitive human breast carcinoma MCF-7 and multidrug-resistant MCF-7/ADR cells.

Y J Lee1, S S Galoforo, C M Berns, G Erdos, A K Gupta, D K Ways, P M Corry.   

Abstract

We studied the effect of ionizing radiation on the activation of the AP-1 transcription factors and the regulation of basic fibroblast growth factor (bFGF) gene expression in drug-sensitive human breast carcinoma (MCF-7) cells and its drug-resistant variant (MCF-7/ADR) cells. Northern blot and gel mobility shift assays showed that 135 cGy of ionizing radiation induced c-jun and c-fos gene expression, AP-1 binding activity, as well as bFGF gene expression in MCF-7/ADR cells. In MCF-7 cells, however, we observed little/no induction of bFGF gene expression and AP-1 binding activity after the stress. Nevertheless, MCF-7 cells transfected with plasmids containing c-jun gene contain high levels of bFGF protein. H-7 (60 micrograms/ml), a potent protein kinase C (PKC) inhibitor, inhibited the stress-induced AP-1 binding activity and bFGF gene expression in MCF-7/ADR cells. Corroborating this observation, overexpression of PKC alpha induced bFGF gene expression in MCF-7 cells. Taken together, these results suggest that stress-induced bFGF gene expression is mediated through the activation of PKC and AP-1 transcription factors. Differences in the levels of PKC activity and AP-1 binding factors may be responsible for differential expression of bFGF among breast cancer cell lines. Although there are large differences in response to ionizing radiation between MCF-7 and MCF-7/ADR cell lines, we observed no significant differences in radiocytotoxicity between them.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7499402     DOI: 10.1074/jbc.270.48.28790

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Hypoxia-induced bFGF gene expression is mediated through the JNK signal transduction pathway.

Authors:  Y J Le; P M Corry
Journal:  Mol Cell Biochem       Date:  1999-12       Impact factor: 3.396

Review 2.  Tumor targeting via EPR: Strategies to enhance patient responses.

Authors:  Susanne K Golombek; Jan-Niklas May; Benjamin Theek; Lia Appold; Natascha Drude; Fabian Kiessling; Twan Lammers
Journal:  Adv Drug Deliv Rev       Date:  2018-07-19       Impact factor: 15.470

3.  Differential effect of glucose deprivation on MAPK activation in drug sensitive human breast carcinoma MCF-7 and multidrug resistant MCF-7/ADR cells.

Authors:  A K Gupta; Y J Lee; S S Galoforo; C M Berns; A A Martinez; P M Corry; X Wu; K L Guan
Journal:  Mol Cell Biochem       Date:  1997-05       Impact factor: 3.396

4.  MicroRNA-21 is involved in ionizing radiation-promoted liver carcinogenesis.

Authors:  Yun Zhu; Xiaoyan Yu; Hanjiang Fu; Hongyan Wang; Ping Wang; Xiaofei Zheng; Ya Wang
Journal:  Int J Clin Exp Med       Date:  2010-07-31

5.  Fungal Extracellular Vesicles as a Potential Strategy for Vaccine Development.

Authors:  Leandro Honorato; Jhon Jhamilton Artunduaga Bonilla; Alicia C Piffer; Leonardo Nimrichter
Journal:  Curr Top Microbiol Immunol       Date:  2021       Impact factor: 4.291

6.  Radiation-induced acid ceramidase confers prostate cancer resistance and tumor relapse.

Authors:  Joseph C Cheng; Aiping Bai; Thomas H Beckham; S Tucker Marrison; Caroline L Yount; Katherine Young; Ping Lu; Anne M Bartlett; Bill X Wu; Barry J Keane; Kent E Armeson; David T Marshall; Thomas E Keane; Michael T Smith; E Ellen Jones; Richard R Drake; Alicja Bielawska; James S Norris; Xiang Liu
Journal:  J Clin Invest       Date:  2013-09-16       Impact factor: 14.808

Review 7.  Immunogenic cell death and DAMPs in cancer therapy.

Authors:  Dmitri V Krysko; Abhishek D Garg; Agnieszka Kaczmarek; Olga Krysko; Patrizia Agostinis; Peter Vandenabeele
Journal:  Nat Rev Cancer       Date:  2012-11-15       Impact factor: 60.716

Review 8.  Biological rationale for the design of polymeric anti-cancer nanomedicines.

Authors:  Yan Zhou; Jindřich Kopeček
Journal:  J Drug Target       Date:  2012-09-26       Impact factor: 5.121

9.  Image-guided and passively tumour-targeted polymeric nanomedicines for radiochemotherapy.

Authors:  T Lammers; V Subr; P Peschke; R Kühnlein; W E Hennink; K Ulbrich; F Kiessling; M Heilmann; J Debus; P E Huber; G Storm
Journal:  Br J Cancer       Date:  2008-09-16       Impact factor: 7.640

10.  The co-delivery of a low-dose P-glycoprotein inhibitor with doxorubicin sterically stabilized liposomes against breast cancer with low P-glycoprotein expression.

Authors:  Wei Gao; Zhiqiang Lin; Meiwan Chen; Xiucong Yang; Zheng Cui; Xiaofei Zhang; Lan Yuan; Qiang Zhang
Journal:  Int J Nanomedicine       Date:  2014-07-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.